MedPath

Epidemiological Study on Asymptomatic Infections and Mild Illness With Covid-19 in Shanghai

Conditions
COVID-19
Registration Number
NCT05375786
Lead Sponsor
Ruijin Hospital
Brief Summary

this study is to clarify the epidemiological characteristics of Omicron variant infected persons in Shanghai, such as distribution characteristics, host and clinical characteristics, disease outcome and risk factors. especially asymptomatic infections.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • SARS-Cov-2 RNA positive.
  • asymptomatic or mild clinical manifestation.
  • informed consent signed.
Exclusion Criteria
  • informed consent rejected.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Viral clearance time2 months

time from viral RNA positive to negative

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ruijin hospital

🇨🇳

Shanghai, Shanghai, China

Ruijin hospital
🇨🇳Shanghai, Shanghai, China
Ying CHEN, Ph D
Contact
+8613917403314
cy11530@rjh.com.cn
Erzhen CHEN, Ph D
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.